CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results
31 mars 2022 16h05 HE
|
CV Sciences, Inc.
SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Reports Second Quarter 2021 Financial Results
12 août 2021 16h05 HE
|
CV Sciences, Inc.
SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021
10 mars 2021 07h00 HE
|
CV Sciences, Inc.
SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction
08 déc. 2020 07h00 HE
|
CV Sciences, Inc.
SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line
29 juil. 2020 08h00 HE
|
CV Sciences, Inc.
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today...
CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2020
30 avr. 2020 16h05 HE
|
CV Sciences, Inc.
SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Reports Fiscal Year-End 2019 Financial Results
16 mars 2020 16h05 HE
|
CV Sciences, Inc.
SAN DIEGO, March 16, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020
26 févr. 2020 08h00 HE
|
CV Sciences, Inc.
SAN DIEGO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Launches Updated +PlusCBD™ Oil Website to Enhance User Experience and Drive Increased E-Commerce Sales
23 janv. 2020 08h45 HE
|
CV Sciences, Inc.
Refreshed Website Guides Visitors on their Hemp CBD Journey with Multimedia Educational Resources, In-Depth Product Information and Improved Shopping Tools Company Well Positioned to Drive Rapid...
Farmers Insurance Open Selects +PlusCBD™ Oil as Their First-Ever CBD Sponsor
21 janv. 2020 08h45 HE
|
CV Sciences, Inc.
SAN DIEGO, Jan. 21, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its...